Table I.
Baseline clinical characteristics of pancreatic cancer patients.
| Variables | Number |
|---|---|
| Gender, male/female | 190/56 |
| Age, yearsa | 63.4±10.92 |
| Alcohol, yes/no | 167/79 |
| Smoking, yes/no | 140/106 |
| Past hemorrhage history, yes/no | 3/243 |
| Past ulcer history, yes/no | 22/224 |
| Past diabetes history, yes/no | 25/221 |
| Past cirrhosis history, yes/no | 30/216 |
| Initial stage, I/II/III/IV | 67/6/29/144 |
| Recived treatment prior to hemorrhage, chemotherapy/concurrent chemoradiotherapy/others | 156/60/30 |
| Initial clinical symptoms, stained yellow/abdominal distension or pain/diabete/ileus/others | 64/132/13/13/24 |
| Tumor location, head of pancreas/body of pancreas/tail of pancreas | 142/49/55 |
| CA19-9 at diagnosis, U/ml | 549.1±967.1 |
| Initial blood pressure | |
| Systolic, mmHga | 138.1±17.2 |
| Diastolic, mmHga | 82.7±11.3 |
| Initial heart ratesa | 92.0±20.1 |
| Hemoglobin, g/dla | 138.3±24.7 |
| Platelet, 109/la | 239.0±67.2 |
| INR/PTT, seca | 1.21±14.7/46.3±41.6 |
a
Mean ± standard deviation. INR, international normalized ratio; PTT, partial thromboplastin time; Hb, hemoglobin; GI, gastrointestinal; CA19-9, carbohydrate antigen 19-9.